CDC25 Inhibition in Acute Myeloid Leukemia–A Study of Patient Heterogeneity and the Effects of Different Inhibitors

By Brenner Annette K.   Reikvam Håkon   Rye Kristin Paulsen   Hagen Karen Marie   Lavecchia Antonio   Bruserud Øystein  

Molecules, Vol. 22, Iss. 3, 2017-03 ,pp. : 446-446

MDPI

Access to resources Recommend Favorite

Human TRIB2 Oscillates during the Cell Cycle and Promotes Ubiquitination and Degradation of CDC25C

By Liang Kai Ling   Paredes Roberto   Carmody Ruaidhri   Eyers Patrick A.   Meyer Stefan   McCarthy Tommie V.   Keeshan Karen  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-08 ,pp. : 1378-1378

MDPI

Access to resources Recommend Favorite

The Expression and Clinical Outcome of pCHK2-Thr68 and pCDC25C-Ser216 in Breast Cancer

By Jiang Huayong   Wang Bin   Zhang Fuli   Qian Yuanyu   Chuang Chia-Chen   Ying Mingzhen   Wang Yajie   Zuo Li  

International Journal of Molecular Sciences, Vol. 17, Iss. 11, 2016-10 ,pp. : 1803-1803

MDPI

Access to resources Recommend Favorite

25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)₂D₃

By Chiang Kun-Chun   Yeh Chun-Nan   Huang Cheng-Cheng   Yeh Ta-Sen   S. Pang Jong-Hwei   Hsu Jun-Te   Chen Li-Wei   Kuo Sheng-Fong   Kittaka Atsushi   Chen Tai C.   Juang Horng-Heng  

International Journal of Molecular Sciences, Vol. 17, Iss. 8, 2016-08 ,pp. : 1326-1326

MDPI

Access to resources Recommend Favorite

Resistance to the Antiproliferative In Vitro Effect of PI3K-Akt-mTOR Inhibition in Primary Human Acute Myeloid Leukemia Cells Is Associated with Altered Cell Metabolism

By Nepstad Ina   Reikvam Håkon   Brenner Annette K.   Bruserud Øystein   Hatfield Kimberley J.  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-01 ,pp. : 382-382

MDPI

Access to resources Recommend Favorite